
Develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Manager Product Owner Vulnerability Management & Effectiveness at BioNTech
About the role
Mainz, Germany | full time | Job ID: 11389
About the Role:
As the Product Owner for Vulnerability Management & Effectiveness, you will oversee our IT vulnerability management program, ensuring effective identification, assessment, and tracking of vulnerabilities. In this strategic advisory role, you will define processes, set up scans, create incidents based on findings, and coordinate remediation efforts with responsible teams. Additionally, you will plan penetration testing and red teaming activities while maintaining the vulnerability management solution. Your focus will be on process management and stakeholder coordination rather than hands-on technical implementation.
Your Contribution:
- Define and implement processes, handbooks, and workflows for vulnerability management
- Maintain the vulnerability management solution, including technical updates such as updating local scanners
- Lead and manage external service providers to ensure effective and proactive vulnerability management
- Collaborate with internal stakeholders to set up scans, including firewall exclusions and tool configurations
- Create incidents based on scan findings, assign them to responsible teams, and follow up to ensure timely resolution
- Provide recommendations for fixing solutions based on tool outputs without direct implementation responsibility
- Plan, scope, and align penetration testing and red teaming activities with internal and external stakeholders
- Work closely with internal teams and external providers to ensure effective vulnerability management and testing coordination
- Ensure vulnerability management processes align with regulatory and organizational compliance requirements
A Good Match:
- Bachelor’s degree in Information Security, Computer Science, or a related field
- Several years of experience in vulnerability management, cybersecurity, or related roles
- Strong knowledge of vulnerability management tools (e.g., Nessus, MS Defender, Qualys, Tenable) and frameworks
- Experience coordinating penetration testing and red teaming activities
- Familiarity with incident management processes and tools
- Proven ability to work collaboratively with cross-functional teams and external providers
- Excellent organizational and project management skills
- Analytical mindset with the ability to interpret scan results and provide actionable recommendations
- Strong communication skills for stakeholder coordination
- Knowledge of cybersecurity standards (e.g., NIST, OSCP, CEH oder HTB CPTS or ISO 27001)
- Fluent English skills, German is a plus
Your Benefits:
It's our priority to support you:
- Your flexibility: flexible hours | vacation account
- Your growth: Digital Learning | Performance & talent development | leadership development | Apprenticeships | LinkedIn Learning
- Your value: Your voice at the table | Culture on an equal footing | Opportunities to shape & impact | Support for your full potential
- Your health and lifestyle: Company bike
- Your mobility: Job ticket | Deutschlandticket
- Your life phases: Employer-funded pension | Childcare
Apply now - We look forward to your application!
Apply to our Mainz, Germany location by sending us your documents via our online form. For any questions, contact our talent acquisition team on: + 49 (0) 6131-9084-1291 (Monday-Friday from 1 PM to 3 PM CET).
Job ID 11389 (please always specify if you have any questions)
By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘Hire Right’. You will be informed accordingly by your BioNTech-Recruiter.
Required skills
vulnerability management
security operations
process design
incident coordination
penetration testing
red teaming
vendor management
Total Views
0
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
More open roles at BioNTech
Similar jobs

Staff Tech, Security, T4
Collins Aerospace (RTX) · US-AZ-TUCSON-M05 ~ 1151 E Hermans Rd ~ BLDG M05 (External Site)

Principal Systems Security Engineer (Cyber) - P4 (Onsite)
Collins Aerospace (RTX) · US-MA-MARLBOROUGH-MA2 ~ 1001 Boston Post Rd ~ BLDG 2

Senior Principal Systems Security Engineer (Cyber) - P5 (Onsite)
Collins Aerospace (RTX) · US-MA-MARLBOROUGH-MA2 ~ 1001 Boston Post Rd ~ BLDG 2

Principal Systems Security Engineer (Cyber) - P4 (Onsite)
Collins Aerospace (RTX) · US-AL-HUNTSVILLE-401 ~ 401 Jan Davis Dr NW ~ JAN DAVIS 401

Network/Security Analyst- Onsite
Collins Aerospace (RTX) · US-MT-GREAT FALLS-6932-CUST ~ 6932 Goddard Dr ~ GODDARD (External Site)
About BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
Employees
Mainz that develops immunotherapies
Headquarters
$21.7B
Valuation
Reviews
10 reviews
4.0
10 reviews
Work-life balance
2.8
Compensation
3.7
Culture
4.2
Career
3.5
Management
3.3
78%
Recommend to a friend
Pros
Innovative and cutting-edge technology projects
Supportive and collaborative team environment
Meaningful and impactful work with strong mission
Cons
Long working hours and high workload
Fast-paced environment can be stressful
High pressure and expectations
Salary Ranges
38 data points
L2
L6
Mid/L4
Intern
L3
L4
L5
L2 · Data Scientist L2
0 reports
$53,767
total per year
Base
$21,507
Stock
$26,884
Bonus
$5,377
$37,637
$69,897
Interview experience
1 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Interview process
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
Common questions
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
Latest updates
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease - WSJ
WSJ
News
·
2w ago
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
News
·
3w ago
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
3w ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3w ago